Rheumatoid Arthritis Unknown Status Phase 4 Trials for Methotrexate (DB00563)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Unknown Status4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00291915Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisTreatment
NCT02275299Study of Iguratimod Plus Methotrexate Compared to Leflunomid Plus Methotrexate in Patients With Rheumatoid ArthritisTreatment
NCT00716248Bucillamine Study of Holding Remission After Infliximab Dose-offPrevention
NCT00523692Remission Induction in Very Early Rheumatoid ArthritisTreatment
NCT01303874Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)Treatment